The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
NCT02856841 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2016-08-05
Summary
44 patients were enrolled in this study as they had malignant epithelial ovarian tumor.Pre-operative staging was assessed by CT scan based on FIGO classification and compared to the standard laparotomy surgical staging. Maximal surgical effort for Optimum cytoreduction was achieved and the risk factors for sub-optimal cytoreduction were studied
Conditions
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Ahmed Maged, MD · Kasr Alainy medical school
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
More Related Trials
-
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
NCT04795596 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Factors Affecting the Prognosis of Early Ovarian Cancer
NCT04414683 ·Status: UNKNOWN
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
NCT05371301 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Surgery in Advanced Ovarian Cancer
NCT03980028 ·Status: COMPLETED
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00075712 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
NCT02291276 ·Status: WITHDRAWN
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
NCT05633199 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NCT02828618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07031908 ·Status: NOT_YET_RECRUITING
-
Debulking Surgery in Ovarian Cancer
NCT03378128 ·Status: COMPLETED ·Phase: NA
-
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT01096394 ·Status: COMPLETED
-
Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
NCT06640348 ·Status: RECRUITING
-
PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors
NCT07271914 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT05287451 ·Status: RECRUITING ·Phase: NA
-
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
NCT01519869 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2
-
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
NCT06385912 ·Status: COMPLETED
-
Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125
NCT02247323 ·Status: UNKNOWN
-
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
NCT00452985 ·Status: COMPLETED
-
Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm
NCT01461850 ·Status: COMPLETED ·Phase: PHASE3
-
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00838656 ·Status: UNKNOWN ·Phase: PHASE2